Navigation Links
PCI Appoints John Davis, PE, to Board
Date:3/14/2013

Raleigh, NC (PRWEB) March 14, 2013

PCI, a leading provider of calibration and maintenance services to the Life Sciences industry is pleased to announce the recent appointment of John Davis, PE, to the PCI Board. Mr. Davis has been a leader in the biotech and pharmaceutical industries for 30 years. He has proven his skills as a leader at various pharmaceutical companies and equally demonstrated his ability to lead as an entrepreneur.

PCI is experiencing exciting growth, with new locations and an increasing client list. The Board plays an integral part, ensuring the PCI success philosophy will positively impact new and existing clients. “PCI is thrilled to have John join our Board. John brings a unique perspective with his consulting company experience and his experience in senior management with large pharmaceutical and biotech operating companies,” said Andy Ferrell, PCI CEO.

Mr. Davis was the founder and president of Serentec, Inc., an international pharmaceutical services firm that was subsequently acquired by Lloyd’s Register in 2002. Currently Associate Director, IT at Biogen Idec, Mr. Davis’ career included leadership and technical roles with Eisai, Glaxo Wellcome, Burroughs-Wellcome, Fluor Daniel and Pitman Moore. He has been involved in IT, process automation, systems design, implementation and validation in the biotech and pharmaceutical industries since 1982.

Earning his B.S. degree in Chemistry from Indiana State University, Mr. Davis is a registered professional engineer and received his MBA from UNC’s Kenan-Flagler School of Business. “I am excited to join the PCI Board. It will be a rewarding experience to be part of such a successful and driven company,” said Mr. Davis.

To see more on the PCI Board Members, visit http://www.pci-llc.com/about/pci-leadership-team/.

About PCI:
PCI was founded in 1996 with a vision of becoming the best consulting and technical services firm in the life sciences industry. The company’s core expertise is calibration and maintenance compliance for FDA-regulated manufacturing facilities and laboratories. PCI’s mission is to provide personalized customer service, exceptional and quality documentation to their customers while always preserving the integrity and ingenuity of performance. The company places high value on honesty, integrity, pride, self-esteem and teamwork. PCI take these values and mission as their primary focus in creating the ultimate result for clients: total compliance in the product quality life cycle.

PCI offers a comprehensive selection of quality services that include Calibration & Maintenance Consulting, Process & Analytical Equipment Calibrations, and ISO 17025 accredited Metrology Laboratory. The company’s six regional offices are located in Boston, Gaithersburg, Indianapolis, Raleigh, San Francisco and Seattle.

To learn more about PCI and its services, visit http://www.pci-llc.com/.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10526855.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. California Healthcare Institute Appoints Vice President-State Government Affairs
2. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
3. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
4. Creabilis Appoints Catherine Moukheibir to its Board of Directors
5. Verenium Appoints Holger Liepmann To Its Board Of Directors
6. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
7. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
8. Avantium Appoints Jonathan Wolfson to its Supervisory Board
9. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
10. PCI Appoints Jose Solorio-Ruiz, MBA, Manager of West Coast Operations
11. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2017)... ... September 17, 2017 , ... GeneOne Life Science, Inc. ... and Drug Safety (KMFDS) for an Investigational New Drug application for a Phase ... coronavirus (MERS-CoV). The study in Korea represents the second clinical trial for GLS-5300. ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... its flexible scientist program (FSP)-- a flexible business approach similar to a ... combines SSCI’s extensive project-based analytical and solid-state chemistry services and expertise with ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... its CliniControl™ (CC) product portfolio, clinically-relevant starting and ancillary materials that generate ... Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product portfolio will radically simplify ...
(Date:9/14/2017)... ... 2017 , ... AxioMed is pleased to announce the success ... completed the procedure on a 35-year-old female patient suffering from degenerative disc disease ... L5-S1. The patient failed conservative treatments prior to undergoing surgery. , Dr. Yang ...
Breaking Biology Technology:
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):